Haemonetics (HAE) EPS (Diluted) Growth (3y) (2012 - 2026)
Haemonetics (HAE) EPS (Diluted) Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.43% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 7.66% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 62.91% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 63.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 30.57% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 29.56% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Haemonetics | 3.50 Bn | 3.26 Bn | 198.21 Mn | -39.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -39.99% |
| Dec 27, 2025 | 13.97% |
| Sep 27, 2025 | 8.06% |
| Jun 28, 2025 | 22.36% |
| Mar 29, 2025 | 81.97% |
| Dec 28, 2024 | 17.94% |
| Sep 28, 2024 | 31.85% |
| Jun 29, 2024 | 119.05% |
| Mar 30, 2024 | 56.66% |
| Dec 30, 2023 | -0.73% |
| Sep 30, 2023 | -19.83% |
| Jul 1, 2023 | 57.36% |
| Apr 1, 2023 | 18.93% |
| Dec 31, 2022 | 3.57% |
| Oct 1, 2022 | -3.70% |
| Jul 2, 2022 | 62.79% |
| Apr 2, 2022 | -21.56% |
| Jan 1, 2022 | 9.32% |
| Oct 2, 2021 | -6.52% |
| Jul 3, 2021 | -17.84% |